Fragile histidine triad expression delays tumor development and induces apoptosis in human pancreatic cancer.

The fragile histidine triad (FHIT) gene is a tumor suppressor gene that is altered by deletion in a large fraction of human tumors, including pancreatic cancer. To evaluate the potential of FHIT gene therapy, we developed recombinant adenoviral and adenoassociated viral (AAV) FHIT vectors and tested these vectors in vitro and in vivo for activity against human pancreatic cancer cells. Our data show that viral FHIT gene delivery results in apoptosis by activation of the caspase pathway. Furthermore, Fhit overexpression enhances the susceptibility of pancreatic cancer cells to exogenous inducers of apoptosis. In vivo results show that FHIT gene transfer delays tumor growth and prolongs survival in a murine model mimicking human disease.

[1]  Y. Lazebnik,et al.  Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation , 2000, Nature Medicine.

[2]  G. Nemerow.  Cell receptors involved in adenovirus entry. , 2000, Virology.

[3]  G. Kroemer,et al.  Mitochondrion as a novel target of anticancer chemotherapy. , 2000, Journal of the National Cancer Institute.

[4]  K. Huebner,et al.  Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression. , 2000, Cancer research.

[5]  F. Behm,et al.  Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN , 2000, Nature Medicine.

[6]  A. Tamanini,et al.  Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions. , 2000, Virology.

[7]  J. Lipski,et al.  An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy. , 2000, Science.

[8]  W. Scheithauer,et al.  Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin , 1999, British Journal of Cancer.

[9]  A. Tucker,et al.  Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus. , 1999, The Journal of clinical investigation.

[10]  P. Wilson,et al.  Transduction of renal cells in vitro and in vivo by adeno-associated virus gene therapy vectors. , 1999, Journal of the American Society of Nephrology : JASN.

[11]  C. Croce,et al.  The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Minna,et al.  Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression. , 1999, Cancer research.

[13]  P. Scardino,et al.  In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial. , 1999, Human gene therapy.

[14]  M. Jäättelä,et al.  Escaping cell death: survival proteins in cancer. , 1999, Experimental cell research.

[15]  K. Huebner,et al.  The FHIT gene is expressed in pancreatic ductular cells and is altered in pancreatic cancers. , 1999, Cancer research.

[16]  D. Grimm,et al.  Novel tools for production and purification of recombinant adenoassociated virus vectors. , 1998, Human gene therapy.

[17]  R. Sherwin,et al.  Peroral gene therapy of lactose intolerance using an adeno-associated virus vector , 1998, Nature Medicine.

[18]  Y. Ogiso,et al.  A comprehensive system to explore p53 mutations. , 1998, American journal of clinical pathology.

[19]  L. Grochow,et al.  A Phase I Clinical Trial of Lethally Irradiated Allogeneic Pancreatic Tumor Cells Transfected with the GM-CSF Gene for the Treatment of Pancreatic Adenocarcinoma. The Johns Hopkins Oncology Center, Baltimore, Maryland , 1998 .

[20]  Junying Yuan,et al.  Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis , 1998, Cell.

[21]  B. Simon,et al.  Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines. , 1998, Cancer research.

[22]  H. Kalthoff,et al.  Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis. , 1998, Cancer research.

[23]  F. Sarkar,et al.  Inhibition of Pancreatic Tumor Cell Growth in Culture by p21WEF1 Recombinant Adenovirus , 1998, Pancreas.

[24]  R. Samulski,et al.  Membrane-Associated Heparan Sulfate Proteoglycan Is a Receptor for Adeno-Associated Virus Type 2 Virions , 1998, Journal of Virology.

[25]  L. D. Barnes,et al.  Replacement of Fhit in cancer cells suppresses tumorigenicity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Bold,et al.  Apoptosis, cancer and cancer therapy. , 1997, Surgical oncology.

[27]  T. Sugimura,et al.  Suppression of Ki‐ras p21 levels leading to growth inhibition of pancreatic cancer cell lines with Ki‐ras mutation but not those without Ki‐ras mutation , 1997, Molecular carcinogenesis.

[28]  T. Sugimura,et al.  Gene therapy for peritoneal dissemination of pancreatic cancer by liposome-mediated transfer of herpes simplex virus thymidine kinase gene. , 1997, Human gene therapy.

[29]  Philip R. Johnson,et al.  Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle. , 1997, Human gene therapy.

[30]  A. Nakagawara,et al.  Inability to induce the alteration of tumorigenicity and chemosensitivity of p53-null human pancreatic carcinoma cells after the transduction of wild-type p53 gene. , 1997, Anticancer research.

[31]  James M. Wilson,et al.  Recombinant adeno-associated virus for muscle directed gene therapy , 1997, Nature Medicine.

[32]  D. Russell,et al.  Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. Samulski,et al.  Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector , 1996, Journal of virology.

[34]  T. Savarese,et al.  Gene deletion chemoselectivity: codeletion of the genes for p16(INK4), methylthioadenosine phosphorylase, and the alpha- and beta-interferons in human pancreatic cell carcinoma lines and its implications for chemotherapy. , 1996, Cancer research.

[35]  C. Croce,et al.  The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract Cancers , 1996, Cell.

[36]  Teruhiko Yoshida,et al.  Liposome-mediated in vivo gene transfer of antisense K-ras construct inhibits pancreatic tumor dissemination in the murine peritoneal cavity. , 1995, Cancer research.

[37]  S. Goodman,et al.  Pancreaticoduodenectomy for Cancer of the Head of the Pancreas 201 Patients , 1995, Annals of surgery.

[38]  D. Russell,et al.  DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors , 1994, Journal of virology.

[39]  N. Kohl,et al.  Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[40]  R. Crystal,et al.  Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA. , 1994, Human gene therapy.

[41]  R. Hruban,et al.  p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. , 1994, Cancer research.

[42]  G. Lauer,et al.  p53 and K-RAS alterations in pancreatic epithelial cell lesions. , 1993, Oncogene.

[43]  N R Lemoine,et al.  Cancer gene therapy: hard lessons and new courses , 2000, Gene Therapy.

[44]  R. Samulski,et al.  AAV vectors: is clinical success on the horizon? , 2000, Gene Therapy.

[45]  Keyun Qing,et al.  Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 , 1999, Nature Medicine.

[46]  John Calvin Reed.  Mechanisms of apoptosis avoidance in cancer. , 1999, Current opinion in oncology.

[47]  Taylor Murray,et al.  Cancer statistics, 1999 , 1999, CA: a cancer journal for clinicians.

[48]  R. Samulski,et al.  αVβ5 integrin: a co-receptor for adeno-associated virus type 2 infection , 1999, Nature Medicine.

[49]  L. Grochow,et al.  A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinoma. , 1998, Human gene therapy.

[50]  L. D. Barnes,et al.  The role of the FHIT/FRA3B locus in cancer. , 1998, Annual review of genetics.

[51]  J. Roth,et al.  Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]. , 1998, Annals of surgical oncology.